Skip to content
MarketScale
‹ Back to IndustriesHealthcare

A New Startup Promises to Preserve Your Brain Intact

If your end-of-life goals include preserving your brain completely intact at the synaptic level so it can potentially be reproduced in microdetail in the distant future and your consciousness reborn, then you’re in luck! A company called Nectome, with financial support from the U.S. National Institute of Mental Health and the startup accelerator Y Combinator,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

If your end-of-life goals include preserving your brain completely intact at the synaptic level so it can potentially be reproduced in microdetail in the distant future and your consciousness reborn, then you’re in luck! A company called Nectome, with financial support from the U.S. National Institute of Mental Health and the startup accelerator Y Combinator, plans to provide you this opportunity.

Nectome has perfectly preserved a pig brain—and amazingly, the brain of a recently deceased woman—using their technique. However, because the process requires the brain’s owner to be alive, the woman’s brain sustained some damage. Their success with the pig brain creates hope for a special population—terminally ill humans who wish to be euthanized using this technique.

Unfortunately, the procedure is literally a suicide mission, which of course raises ethical and legal concerns. Euthanasia is a crime in many states. However, with the end goal being life reproduced, the federal financing targets the development of the process, revitalizing brain research.

Those who undergo the future revival procedure should not expect their consciousness to emerge in the future as themselves. The brain dies in this process, experiencing a combination of cryogenics and embalming. If successful, an identical consciousness with all your precious memories, knowledge, and wisdom would be would be created. That’s a lot to wrap your head around.

Scientists hypothesize that consciousness is a product of the architecture of the neural network instead of some other aspect of the brain, such as its biochemical composition or nucleic acid sequences. Right now, we do not know enough to guarantee specific outcomes. This research would undoubtedly answer many questions. However, as with countless other biomedical experiments, there may be no definitive answers to ethical questions surrounding the wisdom and intentions of manipulating life in this manner. Regardless of these issues, the technique will likely yield promising, much-needed neurological research. And we will be one step closer to solving the mysteries of the human brain.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512